BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2484044)

  • 1. Bacereutin, an antifungal antibiotic isolated from metabolites of Bacillus cereus CHU 130.
    Tschen JS; Tseng CN
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):258-61. PubMed ID: 2484044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and identification of two antifungal cyclic dipeptides from Bacillus cereus subsp. thuringiensis associated with a rhabditid entomopathogenic nematode especially against Fusarium oxysporum.
    Kumar SN; Nambisan B; Mohandas C
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):190-7. PubMed ID: 23402421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycocerein, a novel antifungal peptide antibiotic produced by Bacillus cereus.
    Wakayama S; Ishikawa F; Oishi K
    Antimicrob Agents Chemother; 1984 Dec; 26(6):939-40. PubMed ID: 6441513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and characterization of a novel antifungal peptide APS-1 produced by Bacillus cereus].
    Pei Y; Li X; Peng H; Chen X; Liu J
    Wei Sheng Wu Xue Bao; 1999 Aug; 39(4):344-9. PubMed ID: 12555574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and partial characterization of antifungal metabolites of Bacillus pumilus.
    Munimbazi C; Bullerman LB
    J Appl Microbiol; 1998 Jun; 84(6):959-68. PubMed ID: 9717280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of gallic acid purified from Terminalia nigrovenulosa bark against Fusarium solani.
    Nguyen DM; Seo DJ; Lee HB; Kim IS; Kim KY; Park RD; Jung WJ
    Microb Pathog; 2013 Mar; 56():8-15. PubMed ID: 23333407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YCM1008A, a novel Ca2+-signaling inhibitor, produced by Fusarium sp. YCM1008.
    Koizumi F; Fukumitsu N; Zhao J; Chanklan R; Miyakawa T; Kawahara S; Iwamoto S; Suzuki M; Kakita S; Rahayu ES; Hosokawa S; Tatsuta K; Ichimura M
    J Antibiot (Tokyo); 2007 Jul; 60(7):455-8. PubMed ID: 17721004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the major antifungal substance against Fusarium Sporotrichioides from Chaetomium globosum.
    Jiang C; Song J; Zhang J; Yang Q
    World J Microbiol Biotechnol; 2017 Jun; 33(6):108. PubMed ID: 28466302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solubility of the polyene antibiotics nystatin and levorin in water-organic mixtures].
    Gaidukova TI; Barabanshchikova GV; Bob TG; Etingov ED
    Antibiotiki; 1982 Feb; 27(2):92-5. PubMed ID: 7065651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cispentacin, a new antifungal antibiotic. I. Production, isolation, physico-chemical properties and structure.
    Konishi M; Nishio M; Saitoh K; Miyaki T; Oki T; Kawaguchi H
    J Antibiot (Tokyo); 1989 Dec; 42(12):1749-55. PubMed ID: 2516082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of an antifungal compound, cyclo(l-Pro-d-Leu) for cereals produced by Bacillus cereus subsp. thuringiensis associated with entomopathogenic nematode.
    Nishanth Kumar S; Mohandas C; Nambisan B
    Microbiol Res; 2013 Jun; 168(5):278-88. PubMed ID: 23305769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp.
    Furustrand Tafin U; Meis JF; Trampuz A
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):330-7. PubMed ID: 22694788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification and characterization of antifungal peptide LP-1].
    Liu Y; Xu Q; Chen Z
    Wei Sheng Wu Xue Bao; 1999 Oct; 39(5):441-7. PubMed ID: 12555526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of antifungal peptides from Bacillus BH072, a novel bacterium isolated from honey.
    Zhao X; Zhou ZJ; Han Y; Wang ZZ; Fan J; Xiao HZ
    Microbiol Res; 2013 Nov; 168(9):598-606. PubMed ID: 23545354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Fusarium graminearum inhibitory lipopeptide from Bacillus subtilis IB.
    Wang J; Liu J; Chen H; Yao J
    Appl Microbiol Biotechnol; 2007 Sep; 76(4):889-94. PubMed ID: 17611753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an antifungal compound produced by Bacillus sp. strain A(5) F that inhibits Sclerotinia sclerotiorum.
    Kumar A; Saini S; Wray V; Nimtz M; Prakash A; Johri BN
    J Basic Microbiol; 2012 Dec; 52(6):670-8. PubMed ID: 22359152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varioxepine A, a 3H-oxepine-containing alkaloid with a new oxa-cage from the marine algal-derived endophytic fungus Paecilomyces variotii.
    Zhang P; Mándi A; Li XM; Du FY; Wang JN; Li X; Kurtán T; Wang BG
    Org Lett; 2014 Sep; 16(18):4834-7. PubMed ID: 25167167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the antifungal activity of Acinetobacter baumannii LCH001 in vitro and identification of its antifungal components.
    Liu CH; Chen X; Liu TT; Lian B; Gu Y; Caer V; Xue YR; Wang BT
    Appl Microbiol Biotechnol; 2007 Aug; 76(2):459-66. PubMed ID: 17534613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the antifungal activity of Bacillus vallismortis ZZ185 in vitro and identification of its antifungal components.
    Zhao Z; Wang Q; Wang K; Brian K; Liu C; Gu Y
    Bioresour Technol; 2010 Jan; 101(1):292-7. PubMed ID: 19717300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of peptide antifungal antibiotic and biocontrol activity of Bacillus subtilis.
    Kumar A; Saini P; Shrivastava JN
    Indian J Exp Biol; 2009 Jan; 47(1):57-62. PubMed ID: 19317353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.